Please login to the form below

Not currently logged in
Email:
Password:

Vesomni

This page shows the latest Vesomni news and features for those working in and with pharma, biotech and healthcare.

Astellas gets first OK for prostate drug Vesomni

Astellas gets first OK for prostate drug Vesomni

Astellas' new combination product for enlarged prostate problems in men has been approved in the Netherlands, its first market, under the Vesomni brand name. ... Vesomni (formerly known as EC905) is a once-daily, fixed-dose combination of the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics